Centrexion Therapeutics Corporation

The US Food and Drug Administration asked stakeholders for input on whether pre-approval incentives are needed to encourage the development of new analgesic products, and industry responded by providi

Initial public offerings by biopharmaceutical companies continued to get back on track in the US with a $175m IPO from IGM Biosciences Inc. on 17 September, but Shanghai Henlius Biotech Inc. raise

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Lilly Pays $47.5m Up Front F

While appropriate prescribing practices have grabbed a bulk of the spotlight in the US FDA's strategy to combat the opioid crisis, the agency is gearing up for a deeper dive into another facet of its